Hypoxia-induced TRPM7 promotes glycolytic metabolism and progression in hepatocellular carcinoma
- PMID: 38677534
- DOI: 10.1016/j.ejphar.2024.176601
Hypoxia-induced TRPM7 promotes glycolytic metabolism and progression in hepatocellular carcinoma
Abstract
Background: Hypoxia disrupts glucose metabolism in hepatocellular carcinoma (HCC). Transient receptor potential cation channel, subfamily M, member 7 (TRPM7) plays an ontogenetic role. Thus, we aimed to explore the regulation of TRPM7 by hypoxia-induced factor (HIF) and its underlying mechanisms in HCC.
Methods: hypoxia was induced in multiple HCC cells using 1% O2 or CoCl2 treatment, and subsequently blocked using siRNAs targeting HIF-1α or HIF-2α as well as a HIF-1α protein synthesis inhibitor. The levels of HIF-1α and TRPM7 were assessed using quantitative PCR (qPCR) and Western blot analysis. Chromatin immunoprecipitation (ChIP) and luciferase assays were performed to observe the regulation of TRPM7 promoter regions by HIF-1α. A PCR array was utilized to screen glucose metabolism-related enzymes in HEK293 cells overexpressing TRPM7 induced by tetracycline, and then verified in TRPM7-overexpressed huh7 cells. Finally, CCK-8, transwell, scratch and tumor formation experiments in nude mice were conducted to examine the effect of TRPM7 on proliferation and metastasis in HCC.
Results: Exposure to hypoxia led to increase the levels of TRPM7 and HIF-1α in HCC cells, which were inhibited by HIF-1α siRNA or enhanced by HIF-1α overexpression. HIF-1α directly bound to two hypoxia response elements (HREs) in the TRPM7 promoter. Several glycolytic metabolism-related enzymes, were simultaneously upregulated in HEK293 and huh7 cells overexpressing TRPM7 during hypoxia. In vitro and in vivo experiments demonstrated that TRPM7 promoted the proliferation and metastasis of HCC cells.
Conclusions: TRPM7 was directly transcriptionally regulated by HIF-1α, leading to glycolytic metabolic reprogramming and the promotion of HCC proliferation and metastasis in vitro and in vivo. Our findings suggest that TRPM7 might be a potential diagnostic indicator and therapeutic target for HCC.
Keywords: Glycolysis; HIF-1α; Hepatocellular carcinoma; Hypoxia; TRPM7.
Copyright © 2024 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare no conflict of interest. I declare that this manuscript entitled “Hypoxia-induced TRPM7 Promotes Glycolytic Metabolism and Progression in Hepatocellular Carcinoma” is original, has not been published before and is not currently being considered for publication elsewhere. I would like to draw the attention of the Editor to the following publications of one or more of us that refer to aspects of the manuscript presently being submitted. Where relevant copies of such publications are attached. I confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed. I further confirm that the order of authors listed in the manuscript has been approved by all of us. I understand that the Corresponding Author is the sole contact for the Editorial process. He/she is responsible for communicating with the other authors about progress, submissions of revisions and final approval of proofs.
Similar articles
-
Suppression of TRPM7 Inhibited Hypoxia-Induced Migration and Invasion of Androgen-Independent Prostate Cancer Cells by Enhancing RACK1-Mediated Degradation of HIF-1α.Oxid Med Cell Longev. 2020 Mar 6;2020:6724810. doi: 10.1155/2020/6724810. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32215176 Free PMC article.
-
Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.J Exp Clin Cancer Res. 2021 Feb 17;40(1):72. doi: 10.1186/s13046-021-01868-z. J Exp Clin Cancer Res. 2021. PMID: 33596983 Free PMC article.
-
Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation.Cell Oncol (Dordr). 2021 Oct;44(5):1151-1166. doi: 10.1007/s13402-021-00625-w. Epub 2021 Aug 2. Cell Oncol (Dordr). 2021. PMID: 34339013
-
Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target.World J Gastroenterol. 2015 Nov 14;21(42):12171-8. doi: 10.3748/wjg.v21.i42.12171. World J Gastroenterol. 2015. PMID: 26576101 Free PMC article. Review.
-
The Role of TRPM7 in Oncogenesis.Int J Mol Sci. 2024 Jan 5;25(2):719. doi: 10.3390/ijms25020719. Int J Mol Sci. 2024. PMID: 38255793 Free PMC article. Review.
Cited by
-
TRP channels and cancer modulation: a voyage beyond metabolic reprogramming, oxidative stress and the advent of nanotechnologies in targeted therapy.J Exp Clin Cancer Res. 2025 Aug 14;44(1):240. doi: 10.1186/s13046-025-03495-4. J Exp Clin Cancer Res. 2025. PMID: 40813985 Free PMC article. Review.
-
Hypoxia signaling in cancer: HIF-1α stimulated by COVID-19 can lead to cancer progression and chemo-resistance in oral squamous cell carcinoma (OSCC).Discov Oncol. 2025 Mar 26;16(1):399. doi: 10.1007/s12672-025-02150-w. Discov Oncol. 2025. PMID: 40138101 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous